Here’s a roundup of recent clinical trial and scientific study news:
- Stryker knee, hip implants have lowest revision rates according to study
Stryker Corp.’s (NYSE:SYK) orthopaedics division announced at the 2011 American Academy of Orthopaedic Surgeons annual conference the findings of the National Joint Registry for England and Wales, which reports that Stryker’s Trident Cup, Accolade Hip Stem and Triathlon Knee System outperformed all competitive products in terms of revision rates for the most frequently used brands.
- Study confirms third trimester amniotic fluid a reliable source of stem cells for regenerative medicine
In a study that was presented at the Society for Maternal-Fetal Medicine’s annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking. Amniotic fluid has emerged as one of the most attractive sources of mesenchymal stem cells with broad utility for stem cell therapy development. The stem cells contained in amniotic fluid are multifunctional and can grow into many different organs and tissues.
- Nextrials completes fourth national IHE interoperability trial; showcases Prism at HIMSS
Nextrials Inc. a clinical research software and services firm, will showcase the flexibility and interoperability of its award-winning clinical trial management platform, Prism, at the 2011 Annual Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition, being held February 20-24 at the Orange County Convention Center in Orlando, FL. Prism is one of the clinical research industry’s only electronic data capture (EDC) platforms fully integrated with platforms used for electronic health records by the healthcare industry.
- Study shows improved detection of lung cancer nodules with Riverain Medical’s CAD chest X-ray technology
Riverain Medical, a computer-aided detection (CAD) and advanced visualization technologies firm, announced a poster presentation, “A Superior Chest X-Ray Computer-Aided Detection (CXR CADe) Application: A Reader Study,” has been published on the European Society of Radiology’s website. Investigators compared two versions of Riverain Medical’s computer-aided detection (CAD) technology, OnGuard 5.1 and OnGuard 1.0. The study found radiologists using OnGuard 5.1 were able to detect smaller lung nodules, including those that were primary lung cancer.
- Instead of preventing infections, silver-coated needleless IV connectors may actually cause them
Nationally-acclaimed researcher and award-winning author Cynthia Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent. After testing antimicrobial effectiveness of three different needleless IV connector devices with silver coated or silver impregnated fluid pathway components, Chernecky said that despite FDA clearance of silver coatings, she found they actually grew bugs capable of causing potentially fatal infections.